-
R412947-10mg
RBC10 (C007B-258588)
Price: $289.68List Price: $321.86InformationRBC10 is an inhibitor of Ral binding to RALBP1 (the effector). -
R412947-1mg
RBC10 (C007B-258589)
Price: $99.80List Price: $110.89InformationRBC10 is an inhibitor of Ral binding to RALBP1 (the effector). -
R412947-25mg
RBC10 (C007B-258590)
Price: $555.66List Price: $617.40InformationRBC10 is an inhibitor of Ral binding to RALBP1 (the effector). -
R412947-50mg
RBC10 (C007B-258591)
Price: $814.74List Price: $905.27InformationRBC10 is an inhibitor of Ral binding to RALBP1 (the effector). -
R412947-5mg
RBC10 (C007B-258592)
Price: $182.90List Price: $203.22InformationRBC10 is an inhibitor of Ral binding to RALBP1 (the effector). -
R613179-25mg
Rho kinase inhibitor IV (C007B-415076)
Price: $2,338.71List Price: $2,598.57Rho kinase inhibitor IV. -
R613179-5mg
Rho kinase inhibitor IV (C007B-415077)
Price: $1,623.53List Price: $1,803.92Rho kinase inhibitor IV. -
PHL89903-10MG
ROSARIN (C005B-435974)
Price: $1,231.84List Price: $1,368.71General description This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate. -
S351213-10mg
Saccharin N-(2-Acetic Acid Ethyl Ester)(Piroxicam Impurity E)
Price: $349.17List Price: $387.97Saccharin N-(2-Acetic Acid Ethyl Ester)(Piroxicam Impurity E) is a Piroxicam impurity E. -
S351202-10mg
Saccharin N-(2-Acetic Acid Isopropyl Ester)(Piroxicam Impurity F)
Price: $349.17List Price: $387.97Saccharin N-(2-Acetic Acid Isopropyl Ester)(Piroxicam Impurity F) is a Piroxicam impurity F. -
PHL89784-10MG
SAPONARIN
Price: $1,118.08List Price: $1,242.31General description This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate. -
19315-10
Se-Aspirin-10 mg
Price: $562.48List Price: $624.97A hybrid of selenium and an NSAID that has been shown to reduce the viability of different cancer cell lines, particularly colorectal cancer (CRC) cells (IC<sub>50</sub> = 3.4 µM) inhibits the cell cycle in G1 and G2/M phases and induces